Sampson N S, Kass I J, Ghoshroy K B
Department of Chemistry, State University of New York, Stony Brook 11794-3400, USA.
Biochemistry. 1998 Apr 21;37(16):5770-8. doi: 10.1021/bi973067g.
The function of an active site loop (70-90) of cholesterol oxidase has been ascertained by deleting five contiguous residues (79-83) from the tip of the loop. From the crystal structure of the wild-type enzyme, it appears that this truncation will not significantly perturb the structure of the rest of the enzyme. The UV/vis and CD spectra of the mutant confirm that the enzyme is properly folded with FAD bound. The mutant enzyme still transfers 2H from the 4beta-carbon of the intermediate, cholest-5-en-3-one, to the 6beta-carbon of the product, cholest-4-en-3-one, during isomerization. The kcat/Km of the mutant is increased 6-fold with dehydroepiandrosterone as substrate. Thus, the enzyme is still catalytically active after deletion of the five loop-tip residues. With micellar cholesterol, the kcat/Km of the mutant is decreased 170-fold relative to wild type. This suggests that the tip of the loop is necessary for packing with the "tail" of cholesterol and is responsible for substrate specificity at C17. Increased release of intermediate cholest-5-en-3-one in the mutant-catalyzed reaction is not observed. Truncation of the loop, therefore, does not affect the grip of the enzyme on the intermediate. With lipid vesicle substrates (egg phosphatidylcholine/cholesterol, 1:1), the initial velocity of the mutant is reduced 3000-fold. The binding affinity for the vesicles, however, is only reduced 2-fold. Consequently, the loop is not the primary determinant of binding affinity for vesicles. It is concluded that the loop is important for movement of cholesterol from the lipid bilayer. The tip residues form a hydrophobic pathway between lipid membrane and active site to facilitate movement of substrate and product in to and out of the active site.
通过从胆固醇氧化酶活性位点环(70 - 90)的末端删除五个连续的残基(79 - 83),已确定了该环的功能。从野生型酶的晶体结构来看,这种截短似乎不会显著扰乱酶其余部分的结构。突变体的紫外/可见光谱和圆二色光谱证实该酶在结合FAD的情况下正确折叠。在异构化过程中,突变体酶仍能将中间体胆甾 - 5 - 烯 - 3 - 酮4β - 碳上的2H转移至产物胆甾 - 4 - 烯 - 3 - 酮的6β - 碳上。以脱氢表雄酮为底物时,突变体的催化常数与米氏常数之比(kcat/Km)增加了6倍。因此,在删除五个环末端残基后,该酶仍具有催化活性。对于胶束胆固醇,突变体的kcat/Km相对于野生型降低了170倍。这表明环的末端对于与胆固醇的“尾部”堆积是必需的,并且负责C17位的底物特异性。在突变体催化的反应中未观察到中间体胆甾 - 5 - 烯 - 3 - 酮释放增加。因此,环的截短并不影响酶对中间体的结合。对于脂质囊泡底物(鸡蛋磷脂酰胆碱/胆固醇,1:1),突变体的初始速度降低了3000倍。然而,对囊泡的结合亲和力仅降低了2倍。因此,环不是对囊泡结合亲和力的主要决定因素。得出的结论是,该环对于胆固醇从脂质双层的移动很重要。末端残基在脂质膜和活性位点之间形成疏水通道,以促进底物和产物进出活性位点的移动。